Market Cap

Black Diamond Therapeutics, Inc. Market Capitalization:

$146.7 Million

USD as of July 1, 2025

business Black Diamond Therapeutics, Inc. Company Profile

Black Diamond Therapeutics, Inc. Main Stock Listing

NASDAQ: BDTX

Market Capitalization History of Black Diamond Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Black Diamond Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $141.5 M 0.35%
Jan. 1, 2024 $141.0 M 27.09%
Jan. 1, 2023 $110.9 M -26.86%
Jan. 1, 2022 $151.6 M -83.17%
Jan. 1, 2021 $900.8 M -33.95%
Jan. 1, 2020 $1.36 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Black Diamond Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Black Diamond Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: BDTX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.